Skip to main content
OSR Holdings, Inc. logo

OSR Holdings, Inc. — Investor Relations & Filings

Ticker · OSRH ISIN · US68840D1028 US Professional, scientific and technical activities
Filings indexed 204 across all filing types
Latest filing 2024-05-30 M&A Activity
Country US United States of America
Listing US OSRH

About OSR Holdings, Inc.

https://osr-holdings.com/

OSR Holdings, Inc. is a healthcare holding company that operates using a hub-and-spoke model to manage a diverse portfolio of subsidiary companies. The company's vision is to accelerate healthcare innovation to improve health and wellness outcomes. It actively evaluates and pursues merger and acquisition opportunities that advance innovative healthcare, either by addressing unmet patient needs or by lowering patient costs and burden. The firm's development activities are focused on a portfolio of therapies and healthcare solutions, including oral immunotherapies for cancer treatment, design-augmented biologics, therapeutic antibodies, and engineered proteins.

Recent filings

Filing Released Lang Actions
425 Filing
M&A Activity Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Bellevue Life Sciences Acquisition Corp. It includes disclosures about an amended and restated business combination agreement, changes in the board of directors, and other corporate governance matters. The document references Rule 425 communications, proxy statements, and details about director resignations and appointments. It does not contain comprehensive financial statements or detailed financial performance data typical of annual or quarterly reports. Instead, it focuses on material definitive agreements and management/board changes. Therefore, the document fits best under the category of M&A Activity (TAR) for the business combination agreement update and Board/Management Information (MANG) for the director changes. Since the document covers both but primarily focuses on the business combination agreement amendment and related disclosures, the most appropriate classification is M&A Activity (TAR). The document length and detail support this classification with high confidence.
2024-05-30 English
10-Q
Interim / Quarterly Report Q1 2024
2024-05-15 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the issuance of a promissory note (a financing obligation), an amendment to the company's certificate of incorporation extending the deadline for a business combination, and the results of a shareholder vote on these matters. The document also details financial obligations and shareholder meeting outcomes. This type of filing is typically categorized as a Capital/Financing Update (CAP) because it involves new financial obligations and amendments related to capital structure and financing arrangements. It is not an annual or quarterly report, audit report, earnings release, or other categories. Therefore, the appropriate classification is CAP with high confidence.
2024-05-14 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or disclosures by a company. The text indicates it is a 'Current Report' pursuant to the Securities Exchange Act of 1934, with a specific date of May 13, 2024. The filing includes a press release as Exhibit 99.1 and is furnished under Item 7.01 Regulation FD Disclosure, which typically involves public communications such as press releases or investor updates. The document is relatively short (4094 characters) and does not contain detailed financial statements or substantive financial data. It is primarily an announcement of a press release rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories and often include current reports like Form 8-K filings with press releases.
2024-05-13 English
425 Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Bellevue Life Sciences Acquisition Corp. dated May 13, 2024. It includes a press release reminding stockholders to vote on an extension proposal related to a business combination. The document references a proxy statement filed earlier and discusses voting procedures and solicitation of proxies. There are no financial statements or detailed financial data included, nor is this a full annual or quarterly report. The content focuses on shareholder meeting information, proxy solicitation, and voting results related matters. This fits best under Regulatory Filings (RNS) as it is a current report providing regulatory disclosure about a shareholder meeting and related proxy solicitation, not a full report or earnings release.
2024-05-13 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Bellevue Life Sciences Acquisition Corp. It reports the adjournment of a Special Meeting of Stockholders and related procedural information, including proxy solicitation and redemption request reversal. The document references a Proxy Statement filed earlier but does not contain financial statements or detailed financial analysis. It is primarily an announcement of an event and related procedural updates, not a full financial report or earnings release. The document length is 9743 characters, which is substantial but the content is focused on meeting adjournment and proxy solicitation, typical of a regulatory filing. There is no indication of audit information, earnings data, or management discussion of financial results. Therefore, the best classification is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2024-05-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.